Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor

Trial Phase 3 Completed Nov. 16, 2025

Music Therapy to Prevent Hospital-acquired Delirium in Parkinson's Disease and Dementia With Lewy Bodies

Trial N/A Completed Nov. 12, 2025

Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

Trial Phase 1 Recruiting Nov. 11, 2025

Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease

Trial N/A Active, not recruiting Nov. 4, 2025

Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease

Trial Phase 1 Completed Nov. 3, 2025

Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming

Trial N/A Completed Nov. 3, 2025

Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease

Trial N/A Recruiting Nov. 2, 2025

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

Trial Phase 2 Completed Oct. 30, 2025

A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease

Trial Phase 1 Terminated Oct. 28, 2025

Analysis and Suppression of Tremor During Grasp Using Ultrasound Imaging and Electrical Stimulation

Trial N/A Completed Oct. 26, 2025

rTMS Treatment of Dysphagia in Parkinson's Patients

Trial N/A Completed Oct. 26, 2025

Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease

Trial N/A Enrolling by invitation Oct. 21, 2025

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Trial N/A Recruiting Oct. 21, 2025

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

Trial Phase 2 Terminated Oct. 20, 2025

Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait Using Neural and Kinematic Feedback

Trial N/A Completed Oct. 14, 2025

Motor Training in PD

Trial N/A Completed Oct. 14, 2025

Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD

Trial N/A Recruiting Oct. 14, 2025

Personal KinetiGraph® Clinical Validation Study

Trial N/A Completed Oct. 13, 2025

Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study

Trial N/A Recruiting Oct. 13, 2025

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

Trial Phase 1 Recruiting Oct. 13, 2025